Form 4 Tracker
MapLight Therapeutics, Inc.
MPLT

55 insider filings · Latest: Aug 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 28, 2026Apr 29 8:30 PMJonathan GillisCAAO and PAO
Sale
17,935$30.35$544.3K181,219(D)

View →

Apr 27, 2026Apr 29 8:30 PMJonathan GillisCAAO and PAO
Sale
51,900$29.74$1.5M199,154(D)

View →

Apr 27, 2026Apr 29 8:30 PMAnatol KreitzerChief Discovery Officer
Sale
45,422$29.66$1.3M211,190(D)

View →

Apr 27, 2026Apr 27 8:34 PMANATOL KREITZER
Proposed Sale
45,422$29.76$1.4M

View →

Apr 27, 2026Apr 27 8:32 PMJONATHAN GILLIS
Proposed Sale
69,835$29.76$2.1M

View →

Apr 15, 2026Apr 17 8:05 PMAnatol KreitzerChief Discovery Officer
Sale
3,316$26.61$88.2K256,612(D)

View →

Apr 15, 2026Apr 17 8:05 PMJonathan GillisCAAO and PAO
Sale
3,590$26.61$95.5K251,054(D)

View →

Apr 16, 2026Apr 17 8:05 PMKristopher HansonGeneral Counsel
Sale
298$27.37$8.2K190,165(D)

View →

Apr 15, 2026Apr 17 8:05 PMKristopher HansonGeneral Counsel
Sale
1,529$26.80$41.0K190,463(D)

View →

Apr 16, 2026Apr 17 8:05 PMVishwas SetiaChief Financial Officer
Sale
116$27.37$3.2K392,627(D)

View →

Apr 15, 2026Apr 17 8:05 PMVishwas SetiaChief Financial Officer
Sale
2,806$26.87$75.4K392,743(D)

View →

Apr 16, 2026Apr 17 8:05 PMJames Woodruff LillieChief Scientific Officer
Sale
2,783$27.37$76.2K295,157(D)

View →

Apr 15, 2026Apr 17 8:05 PMJames Woodruff LillieChief Scientific Officer
Sale
1,730$26.82$46.4K297,940(D)

View →

Apr 16, 2026Apr 17 8:05 PMErin Pennock FoffChief Medical Officer
Sale
1,169$27.37$32.0K400,777(D)

View →

Apr 15, 2026Apr 17 8:05 PMErin Pennock FoffChief Medical Officer
Sale
2,044$26.84$54.9K401,946(D)

View →

Apr 16, 2026Apr 17 8:05 PMChristopher A. KroegerDirector, Chief Executive Officer
Sale
10,052$27.37$275.1K1,630,564(D)

View →

Apr 15, 2026Apr 17 8:05 PMChristopher A. KroegerDirector, Chief Executive Officer
Sale
9,135$26.93$246.0K1,640,616(D)

View →

Apr 15, 2026Apr 17 8:05 PMRobert C. MalenkaDirector
Sale
8,593$26.90$231.2K316,466(D)

View →

Apr 15, 2026Apr 15 9:20 PMAnatol Kreitzer
Proposed Sale
5,000$27.02$135.1K

View →

Apr 15, 2026Apr 15 9:15 PMJonathan Gillis
Proposed Sale
4,000$27.02$108.1K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 23, 2026Jun 25 10:04 PMTroy CoxDirector
Grant/Award
29,804$28.6429,804(D)

View →

Jun 23, 2026Jun 25 10:01 PMMartin BablerDirector
Grant/Award
29,804$28.6429,804(D)

View →

Jun 23, 2026Jun 25 9:59 PMTimothy John GarnettDirector
Grant/Award
14,902$28.6414,902(D)

View →

Jun 23, 2026Jun 25 9:57 PMNanna Liebach LuneborgDirector
Grant/Award
14,902$28.6414,902(D)

View →

Jun 23, 2026Jun 25 9:54 PMGeorge PavlovDirector
Grant/Award
14,902$28.6414,902(D)

View →

Jun 23, 2026Jun 25 9:52 PMMaria C WalkerDirector
Grant/Award
14,902$28.6414,902(D)

View →

Feb 5, 2026Feb 9 10:50 PMJonathan GillisCAAO and PAO
Grant/Award
24,455$15.7024,455(D)

View →

Feb 5, 2026Feb 9 10:50 PMVishwas SetiaChief Financial Officer
Grant/Award
31,395$15.7031,395(D)

View →

Feb 5, 2026Feb 9 10:50 PMJames Woodruff LillieChief Scientific Officer
Grant/Award
31,395$15.7031,395(D)

View →

Feb 5, 2026Feb 9 10:50 PMAnatol KreitzerChief Discovery Officer
Grant/Award
24,455$15.7024,455(D)

View →

Feb 5, 2026Feb 9 10:50 PMKristopher HansonGeneral Counsel
Grant/Award
31,395$15.7031,395(D)

View →

Feb 5, 2026Feb 9 10:50 PMErin Pennock FoffChief Medical Officer
Grant/Award
54,240$15.7054,240(D)

View →

Feb 5, 2026Feb 9 10:50 PMChristopher A. KroegerDirector, Chief Executive Officer
Grant/Award
93,955$15.7093,955(D)

View →